Co-beneldopa (Benserazide/levodopa) Prescribing at THE DE PARYS GROUP
Drugs used in parkinsonism and related disorders | Central Nervous System
Items (12m)
616
Total Quantity
87.1K
NHS Cost
£5.8K
vs National Avg
+307.5%
THE DE PARYS GROUP prescribed 616 items of Co-beneldopa (Benserazide/levodopa) over the last 12 months at a cost of £5,771 to the NHS. This is 307.5% above the national average prescribing rate. Co-beneldopa (Benserazide/levodopa) is classified under Drugs used in parkinsonism and related disorders in the BNF.
Monthly Prescribing Trend
Jun 2026
52
Jun 2026
52
Jun 2026
40
Jun 2026
58
Jun 2026
54
Jun 2026
49
Jun 2026
57
Jun 2026
51
Jun 2026
60
Jun 2026
41
Jun 2026
54
Jun 2026
48
Prescribing Details
| Total Items | 616 |
|---|---|
| Total Quantity | 87,100 |
| Total NHS Cost | £5,771 |
| Presentations | 11 different forms |
| vs National Average | +307.5% |
Co-beneldopa (Benserazide/levodopa) Prescribing Comparison
| This practice | 616 items |
|---|---|
| National average per practice | 151 items |
| Difference | +307.5% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.